Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Lupus nephritis Stories

2014-04-01 08:28:06

- Agreement aims to identify biomarkers relevant to future therapies in the area of Systemic Lupus Erythematosus and Lupus Nephritis ROCKLAND, Mass., April 1, 2014 /PRNewswire/ -- EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S. The collaboration is focused on the genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN)...

2014-03-27 12:27:48

New England Patriots defensive back Tavon Wilson serves as Walk Ambassador WASHINGTON, March 27, 2014 /PRNewswire-USNewswire/ -- Multi-talented entertainer and television personality Nick Cannon will serve as the Grand Marshal at the Walk to End Lupus Now(TM) event in Washington, D.C. on Saturday, April 19. Cannon will cut the opening ceremony ribbon and lead the more 4,000 walkers down Pennsylvania Avenue towards the Capitol, shedding light on the cruel mystery that is lupus....

2014-03-18 23:02:43

Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com. According to the report, new product launches are set to fuel SLE and LN treatment markets expansion through to 2022. London, UK (PRWEB) March 18, 2014 The systemic Lupus Erythematosus (SLE) treatment market in the 7 major nations (the US, Germany, France, the UK, Italy, Japan,...

2013-11-19 23:20:20

Reportbuyer.com just published a new market research report: EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022. London (PRWEB) November 19, 2013 EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022 Summary Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to...

2013-10-29 16:26:18

HAYWARD, Calif., Oct. 29, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results, clinical and regulatory update for the quarter ended September 30, 2013. Third Quarter 2013 Financial Results: Net loss for the third quarter of 2013 decreased to $5.8 million from $12.0 million, and loss per basic and diluted share decreased to $0.30 from $1.38, as compared to the same quarter in 2012. Net loss for the nine months ended September 30,...

2013-10-22 08:32:38

Grants Support Research Efforts to Solve the Cruel Mystery of Lupus WASHINGTON, Oct. 22, 2013 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, the only national force dedicated to solving the cruel mystery of lupus, just awarded new grants as part of its 2013-2014 National Research Program. The Foundation presents these awards to support promising areas of research where there is a gap in understanding or where there has not been adequate funding. The Foundation is leading...

2013-09-23 23:34:17

Although Acthar Gel has numerous indications and data suggest that it may be a viable treatment option for resistant nephrotic syndrome, there remains a lack of guidelines on its use. Portland, OR (PRWEB) September 23, 2013 During a recent webinar hosted by AllMed Healthcare Management, Dr. James Wood, board-certified internist and nephrologist, gave an in-depth presentation on the use of Acthar Gel for the treatment of nephrotic syndrome. Although Acthar Gel has numerous indications and...

2013-08-27 23:23:16

This EpiCast report (http://www.reportsnreports.com/reports/267627-epicast-report-systemic-lupus-erythematosus-epidemiology-forecast-to-2022.html ) says Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Dallas, Texas (PRWEB) August 27, 2013 The...

2013-08-14 12:25:29

Summer Issue of Lupus Now® Magazine highlights his journey as an entertainer and public figure living with lupus WASHINGTON, Aug. 14, 2013 /PRNewswire-USNewswire/ -- As a multitalented entertainer and successful television personality and entrepreneur, Nick Cannon has a lot on his plate. The 32-year-old husband and father of two, who battles with lupus nephritis (kidney disease), took on another role: lupus awareness advocate. Cannon has used his voice and platform to raise...

2013-05-22 12:31:26

Launches Global Lupus Nephritis Trials Network NEW YORK, May 22, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI) today is hosting the first international conference devoted to advancing new treatments for lupus nephritis, a serious kidney complication of lupus affecting up to 60 percent of patients. The conference launched a new international alliance of researchers specializing in lupus nephritis - the Lupus Nephritis Trials Network (LNTN). More than 50 of the world's top...